Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
Psychiatrike = Psychiatriki
|
March 7, 2022
Substance use during the COVID-19 pandemic: What is really happening?
Eleftherios Mellos, Thomas Paparrigopoulos
Lancet (London, England)
|
July 26, 2011
Greek academic psychiatry and neurology before the firing squad?
Thomas Paparrigopoulos, Ioannis Liappas
The International Journal of Neuropsychopharmacology
|
October 18, 2008
Zopiclone and sleepwalking
Panagiotis Ferentinos, Thomas Paparrigopoulos
In Vivo (Athens, Greece)
|
October 19, 2010
Comorbidity of personality disorders with alcohol abuse
Eleftherios Mellos, Ioannis Liappas, Thomas Paparrigopoulos
The New England Journal of Medicine
|
January 1, 2008
Sexuality and health among older adults in the United States
Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos
Headache
|
January 16, 2008
Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?
Konstantinos Spengos, Christos Theleritis, Thomas Paparrigopoulos
Journal of Clinical Medicine
|
February 27, 2026
Substance Use Disorders and the Psychosis Spectrum: Assessment, Clinical Challenges and Management
Thomas Paparrigopoulos, Eleftherios Mellos, Charidimos Tzagarakis
The Journal of Clinical Psychiatry
|
March 4, 2008
Quetiapine: another drug with potential for misuse? A case report
Thomas Paparrigopoulos, Dimitris Karaiskos, John Liappas
JAMA
|
April 2, 2009
Triglycerides, depression, and risk of ischemic stroke
Elias Tzavellas, Dimitrios Karaiskos, Thomas Paparrigopoulos
Hepatology (Baltimore, Md.)
|
September 20, 2007
Should impaired liver function be held responsible for cognitive impairment and poor health-related quality of life in alcoholic cirrhosis?
Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
Psychiatrike = Psychiatriki
|
March 7, 2022
Substance use during the COVID-19 pandemic: What is really happening?
Eleftherios Mellos, Thomas Paparrigopoulos
Lancet (London, England)
|
July 26, 2011
Greek academic psychiatry and neurology before the firing squad?
Thomas Paparrigopoulos, Ioannis Liappas
The International Journal of Neuropsychopharmacology
|
October 18, 2008
Zopiclone and sleepwalking
Panagiotis Ferentinos, Thomas Paparrigopoulos
In Vivo (Athens, Greece)
|
October 19, 2010
Comorbidity of personality disorders with alcohol abuse
Eleftherios Mellos, Ioannis Liappas, Thomas Paparrigopoulos
The New England Journal of Medicine
|
January 1, 2008
Sexuality and health among older adults in the United States
Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos
Headache
|
January 16, 2008
Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?
Konstantinos Spengos, Christos Theleritis, Thomas Paparrigopoulos
Journal of Clinical Medicine
|
February 27, 2026
Substance Use Disorders and the Psychosis Spectrum: Assessment, Clinical Challenges and Management
Thomas Paparrigopoulos, Eleftherios Mellos, Charidimos Tzagarakis
The Journal of Clinical Psychiatry
|
March 4, 2008
Quetiapine: another drug with potential for misuse? A case report
Thomas Paparrigopoulos, Dimitris Karaiskos, John Liappas
JAMA
|
April 2, 2009
Triglycerides, depression, and risk of ischemic stroke
Elias Tzavellas, Dimitrios Karaiskos, Thomas Paparrigopoulos
Hepatology (Baltimore, Md.)
|
September 20, 2007
Should impaired liver function be held responsible for cognitive impairment and poor health-related quality of life in alcoholic cirrhosis?
Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos, et al.
Page
of 8